PRODUCTION OF BINDING PROTEINS AND ROLE OF THE INSULIN-LIKE GROWTH FACTOR I BINDING PROTEIN 3 IN HUMAN ARTICULAR CARTILAGE EXPLANTS
Open Access
- 1 June 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 35 (6) , 515-522
- https://doi.org/10.1093/rheumatology/35.6.515
Abstract
The aim of this study was to determine the production of insulin-like growth factor binding proteins (IGFBP) and the role of the IGFBP-3 in human normal (n = 2) and osteoarthritic (OA) articular cartilage (n = 14) explants. Binding proteins were studied in the medium by Western ligand blotting and Western blotting. Proteoglycan synthesis under insulin-like growth factor I (IGF-I) stimulation was studied after a pulse of 35SO2−4 in the presence or absence of added IGFBP-3. Osteoarthritic explants released a doublet of IGFBPs with a 39/43 kDa Mr corresponding to the binding protein 3. Constitutive production from unstimulatcd OA cartilage was higher than from normal cartilage. IGF-1 induced a 20-fold increase and IL-1 a 2-fold increase in IGFBP-3 release. A minor band around 30 kDa was also detectable. Studies of proteoglycan (PG) synthesis showed that the majority of OA cartilage explant samples responded weakly to IGF-I (100 ng/ml) stimulation (+33%), while the others were high responders (+180%). Co-incubation of IGF-I with recombinant (r) IGFBP-3 did not affect the rate of PG synthesis. However, while pre-incubation with rIGFBP3 for 72 h did not change the rate of PG synthesis in the high-responder group, it strongly increased PG synthesis in the low-responder group. This study demonstrates that the ability of IGF-I to enhance proteoglycan synthesis varied among the OA samples and may in part be dependent on the local level of IGFBP-3. This implies pathophysiological considerations in the limits of IGF-I action during the OA process.Keywords
This publication has 0 references indexed in Scilit: